J Korean Child Neurol Soc Search

CLOSE


Ann Child Neurol > Volume 22(1); 2014 > Article
Journal of the Korean Child Neurology Society 2014;22(1):25-28.
DOI: https://doi.org/10.26815/jkcns.2014.22.1.25    Published online March 30, 2014.
Whole Exome Sequencing of a Patient with Duchenne Muscular Dystrophy.
Bong Seok Choi, Su Kyeong Hwang
1Department of Pediatrics, Kyungpook National University, School of Medicine, Daegu, Korea.
2Department of Pediatrics, Kyungpook National University Hospital, Daegu, Korea. neurobaby79@gmail.com
Abstract
Duchenne muscular dystrophy (DMD) is the most common and lethal dystrophy in childhood, caused by mutations in the dystrophin (DMD) gene. Multiplex ligation dependent probe amplification (MLPA) or array comparative genome hybridization (aCGH) is widely used as an initial molecular diagnostic tool. If no deletions or duplications are found in MLPA or aCGH, the samples must be subjected to a second test of direct sequencing. Direct sequencing of the DMD gene, however, is time-consuming, high-cost, and can be inconclusive. Here, we performed whole exome sequencing on a patient with progressive muscle weakness whose MLPA result was negative; the result revealed a rare frame shift mutation. Direct sequencing on the patient's mother showed the same mutation. Whole exome sequencing can be a new diagnostic routine for DMD patients with negative MLPA3.
Key Words: Duchenne muscular dystrophy, dystrophin, High-Throughput DNA Sequencing, genetics, mutation


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
101, Daehak-ro, Jongno-gu, Seoul 03080, Korea
Tel: +82-2-2072-2364    Fax: +82-2-743-3455    E-mail: editor@annchildneurol.org                

Copyright © 2024 by Korean Child Neurology Society.

Developed in M2PI

Close layer
prev next